Response by Zelniker et al to Letter Regarding Article, “Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial”

Details

Language :

English

ISSN :

00097322 and 15244539

Volume :

142

Issue :

10

Database :

Supplemental Index

Journal :

Circulation (Ovid)

Publication Type :

Periodical

Accession number :

ejs54169750

Full Text :

https://doi.org/10.1161/CIRCULATIONAHA.120.049841